Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-07

FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for Pramipexole dihydrochloride from Macleods Pharmaceuticals Limited under ANDA202164.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pramipexole dihydrochloride (pramipexole dihydrochloride)

Snippet

SUPPL AP for PRAMIPEXOLE DIHYDROCHLORIDE (PRAMIPEXOLE DIHYDROCHLORIDE)